DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

4.49 0.05 (1.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARNA $4.49 1.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.41
Previous Close $4.44
Daily Range $4.35 - $4.54
52-Week Range $3.26 - $7.22
Market Cap $1.1B
P/E Ratio -15.86
Dividend (Yield) $0.00 (0.0%)
Volume 1,539,205
Average Daily Volume 3,610,878
Current FY EPS -$0.56

Sector

Healthcare

Industry

Drug Makers

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary

Arena Pharmaceuticals Inc.'s Plan to Win the Obesity Drug War

Building a better mousetrap.

Orexigen: Contrave Sales Pop, Equity Response Muted

Arena: Belviq Scripts Pop, Recover From Previous Dip

Orexigen's Obesity Drug Contrave Faces Generic Threat - Analyst Blog

Orexigen - Contrave Sales Outpace Competition, But Are Still Not Enough

What Novo Nordisk's Entry Into The Obesity Space Means To The Sector

Zacks Rank #5 Additions for Tuesday - Tale of the Tape

3 Promising Small-Caps Under $10 You Can Buy Right Now

These small-cap stocks might be just the thing you're looking for.

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syn

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research

Don't Write Off Arena As Yet

See More ARNA News...

ARNA's Top Competitors

ARNA $4.49 (1.13%)
Current stock: ARNA
GILD $103.70 (-1.44%)
Current stock: GILD
CELG $118.71 (2.26%)
Current stock: CELG
AMGN $167.91 (-0.74%)
Current stock: AMGN